March 2015
Volume 27, No. 3 |
|
|
|
|
|
Focus
Andrew Teasdale, Cyrille C. Chéry, Graham Cook, John Glennon, Carlos W. Lee, Laurence Harris, Nancy Lewen, Samuel Powell, Helmut Rockstroh, Laura Rutter, Lance Smallshaw, Sarah Thompson, Vicki Woodward, and Katherine Ulman
Assessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.
/ read more /
|
|
|
PharmTech Europe March Issue
|
|
|
Featured content
Randi Hernandez
While the optimization of a lyophilization cycle for a biologic relies on a well-characterized formulation, viscosity and aggregation after product reconstitution must also be carefully managed. / read more / |
|
FORMULATION
Adeline Siew, PhD
While the skin offers an alternative route of administration for local and systemic drug delivery, developing semi-solid dosage forms can be a challenge.
/ read more /
|
|
Peer-reviewed research
P.J. Cullen
The pharmaceutical manufacturing platforms of fluid-bed granulation and milling are widely used to modify particle size. However, the adoption of process analytical technology to monitor and control these processes is difficult because of their dynamic nature.
/ read more /
|
|
|
API SYNTHESIS & MANUFACTURING
Cynthia Challener, PhD
Protecting workers, patients, and the environment requires advanced technologies.
/ read more /
|
|
|
TROUBLESHOOTING
William Evans
Several chromatographic resins are available for downstream purification.
/ read more /
|
|
|
REGULATORY WATCH
Sean Milmo
Proposals to make the decentralized procedure more efficient were discussed at the January 2015 EGA conference.
/ read more /
|
|
|
OTHER FEATURES
Siegfried Schmitt
Siegfried Schmitt, Principal Consultant, PAREXEL International, discusses good engineering practices.
/ read more /
|
|
|
|
Events
April 21-23, 2015 | New York
April 23-24, 2015 | London, England
May 05-08, 2015 | Antibes, France
more events
|
|
|
|
|